WeSearch

A single dose reversed autism-like symptoms in adult mice within hours

·7 min read · 0 reactions · 0 comments · 6 views
#single#dose#reversed#autism-like#symptoms
A single dose reversed autism-like symptoms in adult mice within hours
TL;DR · WeSearch summary

Science News from research organizations A single dose reversed autism-like symptoms in adult mice within hours A drug briefly reversed autism-like brain and behavior changes in adult mice, hinting that affected brain circuits may remain surprisingly adaptable. Date: July 25, 2026 Source: University of California - Los Angeles Health Sciences Summary: Even mild inflammation during pregnancy led mouse offspring to develop persistent brain overactivity, sensory sensitivity, repetitive behaviors, and increased seizure risk. Remarkably, one dose of rapamycin improved nearly all of these problems within about two hours.

Key facts
About this source

ScienceDaily files mainly under science. We currently carry 78 of its stories.

Original article
ScienceDaily
Read full at ScienceDaily →
Opening excerpt (first ~120 words) tap to expand

Science News from research organizations A single dose reversed autism-like symptoms in adult mice within hours A drug briefly reversed autism-like brain and behavior changes in adult mice, hinting that affected brain circuits may remain surprisingly adaptable. Date: July 25, 2026 Source: University of California - Los Angeles Health Sciences Summary: Even mild inflammation during pregnancy led mouse offspring to develop persistent brain overactivity, sensory sensitivity, repetitive behaviors, and increased seizure risk. Remarkably, one dose of rapamycin improved nearly all of these problems within about two hours. The benefits were temporary, but they suggest that adult brain circuits may remain far more adaptable than previously believed.

Excerpt limited to ~120 words for fair-use compliance. The full article is at ScienceDaily.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from ScienceDaily